Rating Rationale
October 20, 2023 | Mumbai
SRF Limited
Ratings Reaffirmed
 
Rating Action
Total Bank Loan Facilities RatedRs.1000 Crore
Long Term RatingCRISIL AA+/Stable (Reaffirmed)
Short Term RatingCRISIL A1+ (Reaffirmed)
 
Rs.600 Crore Commercial PaperCRISIL A1+ (Reaffirmed)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has reaffirmed its CRISIL AA+/Stable/CRISIL A1+ ratings on the bank facilities and debt instruments of SRF Limited (SRF).

 

The ratings continue to reflect a strong business risk profile driven by market leadership, diversified revenue, high operating efficiency, and a healthy financial risk profile. These strengths are partially offset by high capex intensity with continuous enhancement in capacities in the specialty chemicals and packaging films segments.

 

In fiscal 2024, operating income is expected to de-grow slightly by ~5-7% y-o-y due to moderation in packaging films business on account of oversupply of BOPET and BOPP films impacting prices. Further, fluorochemicals segment of chemicals business is expected to see some moderation in revenues on account of weak summer impacting domestic sales during Q1 of fiscal 2024 and dumping by China impacting export sales of refrigerant gases. However, revenues of specialty chemicals segment are expected to continue to grow for the current fiscal.

 

During fiscal 2023, operating income increased by 19% to Rs. 14,843 crore driven by higher prices and increase in volume sales of key products. Operating profit before depreciation, interest, and tax (OPBDIT) increased to Rs 3,506 crore (operating margin of 23.6%), as against Rs 3,187 crore (25.6%) for the previous fiscal.

 

The Chemicals Business (CB) segment, forming 50% of the total revenue in 2023, led the growth in FY23 with a 41% growth backed by sustained volumes. For three months ended June 2023, CB segment saw a slight decline in revenues and margins with operating income moderating by ~4% year-on-year to Rs 1,661 crore due to Fluorochemicals Business which witnessed weak domestic demand due to mild summer in India and moderation in exports due to dumping by China. However, performance of CB segment is expected to pick up in the remaining quarters of this fiscal backed by sustained performance of Specialty Chemicals business and expected improvement of Fluorochemicals Business.

 

The Packaging Films Business (PFB) forming around 35% of the total revenue in FY23 posted an increase in operating income of 8% to Rs 5,183 crore. Operating margins for PFB segment were impacted during the fiscal and came down by 600-700 bps compared to last fiscal majorly due to decrease in prices on account of oversupply of BOPET and BOPP films. For three months ended June 2023, operating income in this segment moderated by 27% year-on-year to Rs 1,095 crore with margins sustaining at levels of Q4 fiscal 2023. Fiscal 2024 is expected to continue to see headwinds in the PFB segment due to oversupply alongwith higher energy prices in Europe posing a challenge for SRF’s Hungarian facility. Manufacturing of aluminium foil is expected to start in Q3 fiscal 2024, however, overall contribution to revenues from aluminium foil segment is expected to remain low in fiscal 2024.

 

The technical textiles business (TTB), forming 13% of revenue in fiscal 2023, posted a slight de-growth of 9% with operating income of Rs 1,894 crore due to moderation in raw material prices of Caprolactum. For three months ended June 2023, operating income saw a slowdown with a 19% moderation year-on-year at Rs 465 crore. Moving ahead, revenues and margins in the segment are expected to remain at fiscal 2023 levels.

 

In fiscal 2023, the company completed capex of ~Rs 2,816 crores for capacity expansion and setting up new facilities in the CB and PFB segments. SRF has invested around Rs 1,770 crore p.a. on average on capex in the past 5 years and the company has further capex plan of Rs. 2,700-2,800 crore for fiscal 2024 which will be funded through a mix of internal accruals and debt. Majority of the planned capex will go into chemical business segment for further capacity and product portfolio expansion.

Analytical Approach

For arriving at its ratings, CRISIL has combined the business and financial risk profiles of SRF and all its subsidiaries, as all the entities (together referred to herein as SRF) have the same management and operate in similar businesses.

 

Please refer Annexure - List of entities consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths:

  • Market leadership: The company is the market leader in most of its business segments. Due to extensive experience in handling fluorine, it is the sole producer of some key refrigerants in India. In the specialty chemical segment, continuous investment in research and development (R&D), and improved manufacturing capability have made it a one-of-its-kind player, exporting products that find application in pharmaceutical and agro-based products. In the technical textile business (TTB), the company is the largest nylon tyre cord fabric manufacturer in India, and continued addition of new value-added products in the belting fabrics and polyester industrial yarn segment (part of the TTB) should further enhance the market position. The market position in the packaging films business (PFB) is supported by large capacity and high volume of value-added products. The healthy market position is likely to be sustained, given the leadership position, established track record, and large R&D capability leading to technical expertise.

 

  • Diversified revenue and high operating efficiency: SRF has a diversified revenue profile with presence across CB (50%), PFB (35%) and TTB (13%) segments in terms of revenue in fiscal 2023. The management has successfully diversified its geographical presence through investments in the PFB segment in South Africa, Thailand, and Hungary. The diversified revenue profile protects against downswing in any one business and keeps the operating margin steady. Furthermore, cost efficiency measures in the TTB and PFB segments, strong R&D capability in specialty chemicals, and market leadership in refrigerants have helped in keeping the margin higher than that of peers.

 

  • Strong financial risk profile: The financial risk profile remains strong backed by robust tangible networth leading to a comfortable gearing of 0.43 time as on March 31, 2023. Cash accrual was healthy at Rs 2,524 core in fiscal 2023, resulting in comfortable debt protection metrics, indicated by net cash accruals to adjusted debt at 0.58 times (0.53 times previous fiscal). The financial robustness is also explained by interest coverage ratio which stands at 17.5 times (27.8 times previous fiscal) and is expected to continue with net cash accruals estimated at around Rs 2,000 crore for fiscal 2024 which will be used to fund the capex requirements along with mix of some debt.

 

Weakness:

  • High capex intensity: The company is continuously incurring capex in specialty chemicals of the CB segment and is also expanding manufacturing facilities of other segments. Capex was around Rs 2816 crore in fiscal 2023. SRF has invested around Rs 1770 crore every year on capex building in the last 5 years and the company has further capex plan of Rs 2800-2900 crore for fiscal 2024 out of which majority will go into chemical business segment. However, profitability of a molecule in the CB segment depends on successful commercialization and acceptability, while cyclicality is inherent in the PFB and TTB segments. Therefore, the ability to maintain strong revenue growth and sustain the operating margin will remain a key monitorable.

Liquidity: Strong

The liquidity profile of the company continues to remain strong, with healthy cash accruals of Rs 2,524 crores along with cash and cash equivalents of Rs 608 crores as of March 2023 against term debt repayments of Rs 491 crore in fiscal 2024. Liquidity is further supported by unutilized bank lines with an average 48% fund-based utilisation in the last 6 months. Also, financial flexibility continues to remain robust as company has access to capital markets through CPs as well as NCDs. The combined capex for fiscals 2024 and 2025 is expected at Rs 5,000-5,500 crore and should be funded largely by internal accrual and some through debt.

Outlook: Stable

CRISIL Ratings believes SRF will continue to benefit from its market leadership and healthy operating efficiency, while the financial risk profile should remain comfortable due to adequate cash accrual, over the medium term.

Rating Sensitivity factors

Upward factors

  • Sustenance of the gross debt/EBITDA ratio at below 1.0 time
  • Strong revenue growth, with sustained improvement in the operating margin, leading to higher cash accrual 

 

Downward factors

  • A sustained increase in the gross debt/EBITDA ratio to more than 2 times
  • A sustained decline in the operating margin with stagnant revenue leading to lower cash accrual

 

ESG analysis

ESG profile of SRF Supports its strong credit risk profile

 

The chemical manufacturers can have a significant impact on the environment owing to high water consumption, waste generation and greenhouse gas (GHG) emissions. The sector’s social impact is characterized by health hazards, leading to higher focus on employee safety and well-being and the impact on local community, given the nature of its operations. SRF has continuously focused on mitigating its environmental and social risks.

 

Key ESG highlights

  • SRF has a total of 18.95 MW installed capacity of renewable energy, which includes an onsite 5 MW solar power plant and an offsite 13.95 MW wind power plant.
  • SRF incorporates ESG aspects related to health and safety, human rights, labor laws, environment etc. within the supplier agreements and follows a code of conduct to assess the ESG performance of suppliers.
  • SRF is committed towards fostering a diverse and inclusive workplace, free from any sort of harassment and/or discrimination based on gender identity, age, ethnicity, sexual orientation, disability, faith, or marital status.
  • The governance structure is characterized by 60% of the board comprising independent directors, presence of an investor grievance redressal mechanism and extensive disclosures.

 

There is a growing importance of ESG among investors and lenders. The commitment of SRF to the ESG principle will play a key role in enhancing stakeholder confidence given shareholding foreign portfolio investors and access to both domestic and foreign capital markets.

About the Company

SRF is a multi-business chemicals conglomerate engaged in the manufacturing of industrial and specialty intermediates. Incorporated in 1970, SRF started operations with a Nylon Tyre Cord plant in Manali, Tamilnadu. It is currently present in CB, PFB and TTB and Others business verticals with a revenue contribution of 50%, 35% and 13% and 2% respectively in fiscal 2023. Under the CB segment, the company manufactures fluoro-chemicals (including refrigerant gases, blends and chloromethanes) and specialty chemicals. In the PFB segment it manufactures biaxally oriented polypropylene (BOPP) and biaxally oriented polypropylene terephthalate (BOPET) used in flexible package covers and labels. In the TTB segment, it manufactures nylon cord fabrics, belting fabrics, and industrial yarn. SRF has 11 manufacturing units in India and one each in South Africa, Thailand, and Hungary. Its sales are spread across more than 90 countries, and it has a workforce of more than 7000 employees. Presently India accounts for 40% of revenues followed by USA (15%), Switzerland (6%), Belgium (6%), South Africa (4%), Thailand (4%), Germany (3%), and rest of the world (22%). The parent company Kama Holdings Ltd. holds 51% stake while the other 49% is held by the public.

 

For the three months ended June 30, 2023, operating income and profit after tax (PAT) were Rs 3,338 crore and Rs 359 crore, respectively, against Rs 3,895 crore and Rs 608 crore, respectively, for the corresponding period of the previous fiscal.

Key Financial Indicators (CRISIL Ratings adjusted financials)

As on / for period ended March 31

Unit

2023

2022

Revenue

Rs crore

14,843

12,434

PAT

Rs crore

2,162

1,889

PAT margin

%

14.6

15.2

Adjusted debt/adjusted networth

Times

0.43

0.42

Interest coverage

Times

17.5

27.8

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the 'Annexure - Details of Instrument' in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities - including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisilratings.com. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of instrument

Date of allotment

Coupon rate (%)

Maturity date

Issue size

(Rs crore)

Complexity Level

Rating assigned with outlook

NA

External Commercial Borrowings*

NA

NA

Nov-27

208.0

NA

CRISIL AA+/Stable

NA

External Commercial Borrowings#

NA

NA

Oct-23

249.0

NA

CRISIL AA+/Stable

NA

Foreign Currency Term Loan**

NA

NA

Mar-25

277.0

NA

CRISIL AA+/Stable

NA

Working Capital Facility

NA

NA

NA

50

NA

CRISIL A1+

NA

Proposed Term Loan

NA

NA

NA

216

NA

CRISIL AA+/Stable

NA

Commercial paper

NA

NA

7-365 days

600.0

Simple

CRISIL A1+

*Equivalent to USD 25 million

#Equivalent to USD 30 million

**Equivalent to USD 33.39 million

Annexure – List of entities consolidated

Names of entities consolidated

Country of incorporation

Proportion of ownership

Extent of consolidation

Rationale for consolidation

SRF Holiday Home Limited

India

100%

Fully consolidated

Strong business and financial linkages

SRF Global BV

Netherlands

100%

Fully consolidated

Strong business and financial linkages

SRF Industries (Thailand) Limited

Thailand

100%

Fully consolidated

Strong business and financial linkages

SRF Industex Belting (Pty) Limited

South Africa

100%

Fully consolidated

Strong business and financial linkages

SRF Flexipak (South Africa) (Pty) Limited

South Africa

100%

Fully consolidated

Strong business and financial linkages

SRF Europe Kft

Hungary

100%

Fully consolidated

Strong business and financial linkages

SRF Altech Ltd.

India

100%

Fully consolidated

Strong business and financial linkages

 

Annexure - Rating History for last 3 Years
  Current 2023 (History) 2022  2021  2020  Start of 2020
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT/ST 1000.0 CRISIL AA+/Stable / CRISIL A1+   -- 24-11-22 CRISIL AA+/Stable / CRISIL A1+ 03-09-21 CRISIL AA+/Stable / CRISIL A1+ 09-09-20 CRISIL AA+/Stable / CRISIL A1+ CRISIL AA+/Stable
      --   -- 01-09-22 CRISIL AA+/Stable / CRISIL A1+   -- 21-04-20 CRISIL AA+/Stable / CRISIL A1+ --
Commercial Paper ST 600.0 CRISIL A1+   -- 24-11-22 CRISIL A1+ 03-09-21 CRISIL A1+ 09-09-20 CRISIL A1+ CRISIL A1+
      --   -- 01-09-22 CRISIL A1+   -- 21-04-20 CRISIL A1+ --
Non Convertible Debentures LT   --   -- 24-11-22 Withdrawn 03-09-21 CRISIL AA+/Stable 09-09-20 CRISIL AA+/Stable CRISIL AA+/Stable
      --   -- 01-09-22 CRISIL AA+/Stable   -- 21-04-20 CRISIL AA+/Stable --
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
External Commercial Borrowings# 249 The Hongkong and Shanghai Banking Corporation Limited CRISIL AA+/Stable
Proposed Term Loan 216 Not Applicable CRISIL AA+/Stable
External Commercial Borrowings* 208 State Bank of India CRISIL AA+/Stable
Working Capital Facility 50 YES Bank Limited CRISIL A1+
Foreign Currency Term Loan** 277 Kotak Mahindra Bank Limited CRISIL AA+/Stable

*Equivalent to USD 25 million

#Equivalent to USD 30 million

**Equivalent to USD 33.39 million

Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Chemical Industry
CRISILs Criteria for rating short term debt
CRISILs Criteria for Consolidation

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Mohit Makhija
Senior Director
CRISIL Ratings Limited
B:+91 124 672 2000
mohit.makhija@crisil.com


Gautam Shahi
Director
CRISIL Ratings Limited
B:+91 124 672 2000
gautam.shahi@crisil.com


SUMAN ROY
Manager
CRISIL Ratings Limited
B:+91 124 672 2000
SUMAN.ROY@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited, an S&P Global Company)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a leading, agile and innovative global analytics company driven by its mission of making markets function better. 

It is India’s foremost provider of ratings, data, research, analytics and solutions with a strong track record of growth, culture of innovation, and global footprint.

It has delivered independent opinions, actionable insights, and efficient solutions to over 100,000 customers through businesses that operate from India, the US, the UK, Argentina, Poland, China, Hong Kong and Singapore.

It is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.

For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL's privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale ('report') that is provided by CRISIL Ratings Limited ('CRISIL Ratings'). To avoid doubt, the term 'report' includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, 'CRISIL Ratings Parties') guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix 'PP-MLD' for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html